Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station.

University of Wisconsin–Madison researchers have developed a promising technique for treating osteoarthritis using ...

Goldman Sachs downgraded Moderna (MRNA) to Neutral from Buy with a price target of $51, down from $99. The recent product revenue guidance ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...

Continued development of DPX-mRNA formulations is one of the Company's objectives, with BioVaxys pursuing collaborations with ...

In the latest trading session, Moderna (MRNA) closed at $41.66, marking a +0.6% move from the previous day. The S&P 500 logs the best first week of a presidential term in four decades. Here are ...

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating ...